annual D&A:
$361.74M+$47.62M(+15.16%)Summary
- As of today (May 29, 2025), CRL annual depreciation & amortization is $361.74 million, with the most recent change of +$47.62 million (+15.16%) on December 28, 2024.
- During the last 3 years, CRL annual D&A has risen by +$96.20 million (+36.23%).
- CRL annual D&A is now at all-time high.
Performance
CRL Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$120.36M+$18.26M(+17.88%)Summary
- As of today (May 29, 2025), CRL quarterly depreciation & amortization is $120.36 million, with the most recent change of +$18.26 million (+17.88%) on March 29, 2025.
- Over the past year, CRL quarterly D&A has increased by +$35.01 million (+41.01%).
- CRL quarterly D&A is now at all-time high.
Performance
CRL quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$396.75M+$35.01M(+9.68%)Summary
- As of today (May 29, 2025), CRL TTM depreciation & amortization is $396.75 million, with the most recent change of +$35.01 million (+9.68%) on March 29, 2025.
- Over the past year, CRL TTM D&A has increased by +$74.34 million (+23.06%).
- CRL TTM D&A is now at all-time high.
Performance
CRL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CRL Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +15.2% | +41.0% | +23.1% |
3 y3 years | +36.2% | +59.9% | +42.0% |
5 y5 years | +82.6% | +110.2% | +88.9% |
CRL Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +36.2% | at high | +61.3% | at high | +42.0% |
5 y | 5-year | at high | +82.6% | at high | +110.4% | at high | +88.9% |
alltime | all time | at high | +3220.3% | at high | +6700.2% | at high | +5114.9% |
CRL Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $120.36M(+17.9%) | $396.75M(+9.7%) |
Dec 2024 | $361.74M(+15.2%) | $102.10M(+15.8%) | $361.74M(+6.3%) |
Sep 2024 | - | $88.20M(+2.5%) | $340.15M(+2.8%) |
Jun 2024 | - | $86.08M(+0.8%) | $330.82M(+2.6%) |
Mar 2024 | - | $85.36M(+6.0%) | $322.41M(+2.6%) |
Dec 2023 | $314.12M(+3.4%) | $80.51M(+2.1%) | $314.12M(+1.0%) |
Sep 2023 | - | $78.87M(+1.5%) | $311.15M(+1.4%) |
Jun 2023 | - | $77.67M(+0.8%) | $306.89M(+0.4%) |
Mar 2023 | - | $77.07M(-0.6%) | $305.64M(+0.6%) |
Dec 2022 | $303.87M(+14.4%) | $77.55M(+3.9%) | $303.87M(+3.5%) |
Sep 2022 | - | $74.61M(-2.4%) | $293.57M(+2.1%) |
Jun 2022 | - | $76.42M(+1.5%) | $287.65M(+3.0%) |
Mar 2022 | - | $75.30M(+12.0%) | $279.33M(+5.2%) |
Dec 2021 | $265.54M(+13.0%) | $67.24M(-2.1%) | $265.54M(+2.5%) |
Sep 2021 | - | $68.69M(+0.9%) | $259.18M(+3.6%) |
Jun 2021 | - | $68.11M(+10.7%) | $250.07M(+4.6%) |
Mar 2021 | - | $61.51M(+1.0%) | $239.17M(+1.8%) |
Dec 2020 | $234.92M(+18.6%) | $60.88M(+2.2%) | $234.92M(+4.0%) |
Sep 2020 | - | $59.58M(+4.1%) | $225.88M(+3.6%) |
Jun 2020 | - | $57.21M(-0.1%) | $218.06M(+3.8%) |
Mar 2020 | - | $57.26M(+10.5%) | $210.00M(+6.0%) |
Dec 2019 | $198.09M(+22.4%) | $51.83M(+0.1%) | $198.09M(+5.5%) |
Sep 2019 | - | $51.76M(+5.3%) | $187.84M(+4.5%) |
Jun 2019 | - | $49.15M(+8.4%) | $179.68M(+3.3%) |
Mar 2019 | - | $45.36M(+9.1%) | $173.93M(+7.5%) |
Dec 2018 | $161.78M(+23.3%) | $41.58M(-4.6%) | $161.78M(+5.3%) |
Sep 2018 | - | $43.59M(+0.5%) | $153.68M(+7.1%) |
Jun 2018 | - | $43.40M(+30.7%) | $143.56M(+8.8%) |
Mar 2018 | - | $33.21M(-0.8%) | $131.96M(+0.6%) |
Dec 2017 | $131.16M(+3.6%) | $33.48M(+0.1%) | $131.16M(-1.5%) |
Sep 2017 | - | $33.47M(+5.2%) | $133.22M(-0.5%) |
Jun 2017 | - | $31.80M(-1.9%) | $133.86M(-0.4%) |
Mar 2017 | - | $32.41M(-8.8%) | $134.41M(+6.1%) |
Dec 2016 | $126.66M(+33.5%) | $35.54M(+4.2%) | $126.66M(+8.6%) |
Sep 2016 | - | $34.11M(+5.4%) | $116.67M(+9.7%) |
Jun 2016 | - | $32.35M(+31.2%) | $106.37M(+9.5%) |
Mar 2016 | - | $24.66M(-3.5%) | $97.17M(+2.4%) |
Dec 2015 | $94.88M(-1.6%) | $25.55M(+7.3%) | $94.88M(-0.5%) |
Sep 2015 | - | $23.81M(+2.9%) | $95.34M(-2.3%) |
Jun 2015 | - | $23.15M(+3.5%) | $97.61M(-1.2%) |
Mar 2015 | - | $22.37M(-14.0%) | $98.76M(+2.4%) |
Dec 2014 | $96.44M(-0.2%) | $26.01M(-0.3%) | $96.44M(-3.3%) |
Sep 2014 | - | $26.08M(+7.3%) | $99.73M(-0.8%) |
Jun 2014 | - | $24.30M(+21.2%) | $100.57M(+4.0%) |
Mar 2014 | - | $20.05M(-31.6%) | $96.68M(+0.0%) |
Dec 2013 | $96.64M(+18.9%) | $29.30M(+8.9%) | $96.64M(+9.8%) |
Sep 2013 | - | $26.92M(+31.9%) | $87.99M(+7.8%) |
Jun 2013 | - | $20.41M(+2.0%) | $81.63M(+0.4%) |
Mar 2013 | - | $20.01M(-3.1%) | $81.28M(+0.0%) |
Dec 2012 | $81.28M | $20.66M(+0.5%) | $81.28M(-0.4%) |
Sep 2012 | - | $20.55M(+2.4%) | $81.60M(-0.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $20.07M(+0.3%) | $82.22M(-2.1%) |
Mar 2012 | - | $20.00M(-4.7%) | $83.97M(-1.5%) |
Dec 2011 | $85.23M(-9.0%) | $20.98M(-0.9%) | $85.23M(-3.0%) |
Sep 2011 | - | $21.17M(-3.0%) | $87.91M(-2.6%) |
Jun 2011 | - | $21.82M(+2.6%) | $90.22M(-1.2%) |
Mar 2011 | - | $21.27M(-10.1%) | $91.33M(-2.5%) |
Dec 2010 | $93.65M(+4.1%) | $23.66M(+0.7%) | $93.65M(+3.8%) |
Sep 2010 | - | $23.48M(+2.4%) | $90.24M(-1.5%) |
Jun 2010 | - | $22.93M(-2.8%) | $91.60M(+0.0%) |
Mar 2010 | - | $23.58M(+16.4%) | $91.57M(+1.8%) |
Dec 2009 | $89.96M(-1.3%) | $20.25M(-18.5%) | $89.96M(-2.8%) |
Sep 2009 | - | $24.84M(+8.5%) | $92.53M(+2.1%) |
Jun 2009 | - | $22.90M(+4.2%) | $90.67M(-0.1%) |
Mar 2009 | - | $21.97M(-3.8%) | $90.81M(-0.4%) |
Dec 2008 | $91.18M(+5.6%) | $22.83M(-0.6%) | $91.18M(+1.7%) |
Sep 2008 | - | $22.97M(-0.3%) | $89.67M(+0.4%) |
Jun 2008 | - | $23.04M(+3.1%) | $89.28M(+1.3%) |
Mar 2008 | - | $22.35M(+4.9%) | $88.11M(+2.0%) |
Dec 2007 | $86.38M(+1.5%) | $21.31M(-5.6%) | $86.38M(-1.4%) |
Sep 2007 | - | $22.59M(+3.3%) | $87.60M(+1.3%) |
Jun 2007 | - | $21.87M(+6.1%) | $86.50M(+0.9%) |
Mar 2007 | - | $20.61M(-8.5%) | $85.71M(+0.7%) |
Dec 2006 | $85.13M(-5.5%) | $22.54M(+4.9%) | $85.13M(+13.5%) |
Sep 2006 | - | $21.48M(+1.9%) | $75.02M(-12.9%) |
Jun 2006 | - | $21.09M(+5.3%) | $86.16M(+2.5%) |
Mar 2006 | - | $20.03M(+61.2%) | $84.08M(-6.7%) |
Dec 2005 | $90.12M(+105.1%) | $12.43M(-61.9%) | $90.12M(-6.9%) |
Sep 2005 | - | $32.62M(+71.7%) | $96.82M(+33.2%) |
Jun 2005 | - | $19.00M(-27.1%) | $72.68M(+17.6%) |
Mar 2005 | - | $26.07M(+36.3%) | $61.82M(+40.7%) |
Dec 2004 | $43.93M(+41.2%) | $19.13M(+125.5%) | $43.93M(+30.6%) |
Sep 2004 | - | $8.48M(+4.2%) | $33.64M(+2.5%) |
Jun 2004 | - | $8.14M(-0.5%) | $32.81M(+2.1%) |
Mar 2004 | - | $8.18M(-7.5%) | $32.12M(+3.2%) |
Dec 2003 | $31.12M(+21.0%) | $8.84M(+15.5%) | $31.12M(+6.6%) |
Sep 2003 | - | $7.65M(+2.7%) | $29.18M(+2.9%) |
Jun 2003 | - | $7.45M(+3.8%) | $28.37M(+4.7%) |
Mar 2003 | - | $7.18M(+4.0%) | $27.10M(+5.3%) |
Dec 2002 | $25.73M(-10.0%) | $6.90M(+0.9%) | $25.73M(-5.0%) |
Sep 2002 | - | $6.84M(+10.7%) | $27.09M(-2.3%) |
Jun 2002 | - | $6.18M(+6.4%) | $27.73M(-2.7%) |
Mar 2002 | - | $5.81M(-29.7%) | $28.49M(-0.3%) |
Dec 2001 | $28.58M(+51.4%) | $8.26M(+10.4%) | $28.58M(+13.7%) |
Sep 2001 | - | $7.48M(+7.7%) | $25.13M(+12.5%) |
Jun 2001 | - | $6.95M(+17.9%) | $22.33M(+30.2%) |
Mar 2001 | - | $5.89M(+22.4%) | $17.15M(-9.1%) |
Dec 2000 | $18.87M(+20.6%) | $4.81M(+2.9%) | $18.87M(+34.2%) |
Sep 2000 | - | $4.68M(+164.4%) | $14.06M(+49.9%) |
Jun 2000 | - | $1.77M(-76.7%) | $9.38M(+23.3%) |
Mar 2000 | - | $7.61M | $7.61M |
Dec 1999 | $15.64M(+43.6%) | - | - |
Dec 1998 | $10.89M | - | - |
FAQ
- What is Charles River Laboratories International annual depreciation & amortization?
- What is the all time high annual D&A for Charles River Laboratories International?
- What is Charles River Laboratories International annual D&A year-on-year change?
- What is Charles River Laboratories International quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly D&A year-on-year change?
- What is Charles River Laboratories International TTM depreciation & amortization?
- What is the all time high TTM D&A for Charles River Laboratories International?
- What is Charles River Laboratories International TTM D&A year-on-year change?
What is Charles River Laboratories International annual depreciation & amortization?
The current annual D&A of CRL is $361.74M
What is the all time high annual D&A for Charles River Laboratories International?
Charles River Laboratories International all-time high annual depreciation & amortization is $361.74M
What is Charles River Laboratories International annual D&A year-on-year change?
Over the past year, CRL annual depreciation & amortization has changed by +$47.62M (+15.16%)
What is Charles River Laboratories International quarterly depreciation & amortization?
The current quarterly D&A of CRL is $120.36M
What is the all time high quarterly D&A for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly depreciation & amortization is $120.36M
What is Charles River Laboratories International quarterly D&A year-on-year change?
Over the past year, CRL quarterly depreciation & amortization has changed by +$35.01M (+41.01%)
What is Charles River Laboratories International TTM depreciation & amortization?
The current TTM D&A of CRL is $396.75M
What is the all time high TTM D&A for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM depreciation & amortization is $396.75M
What is Charles River Laboratories International TTM D&A year-on-year change?
Over the past year, CRL TTM depreciation & amortization has changed by +$74.34M (+23.06%)